Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
May 23, 2016
Finance
Venturing west
...spinouts include nocturia therapeutic developer Tacurion Pharma Inc. and gastrointestinal companies Seldar Pharma Inc. and
Telsar Pharma Inc.
...
Read More
BioCentury
|
May 13, 2013
Company News
Drais, Tacurion, Astellas deal
...In a pair of similar deals announced last year, Astellas and Drais formed virtual companies
Telsar Pharma Inc.
...
Read More
BioCentury
|
May 8, 2013
Company News
Astellas, Drais form newco to develop Astellas nocturia compound
...In a pair of similar deals announced last year, Astellas and Drais formed virtual companies
Telsar Pharma Inc.
...
Read More
BioCentury
|
Jun 5, 2012
Company News
Astellas, Drais form newco to develop Astellas' IBS product
...milestone payment and royalties. In a similar deal in April, the partners formed virtual company
Telsar Pharma Inc.
...
Read More
BioCentury
|
Apr 30, 2012
Financial News
Telsar Pharma completes venture financing
Telsar Pharma Inc.
, Bridgewater, N.J. Business: Gastrointestinal Date completed: 4/24/12 Type: Venture financing Raised: $14 million Investors: InterWest Partners; Sutter Hill Ventures; Astellas Venture Management WIR Staff...
Read More
BioCentury
|
Apr 26, 2012
Company News
Astellas, Drais form newco to develop Astellas' ASP3291
...Astellas Pharma Inc. (Tokyo:4503) and Drais Pharmaceuticals Inc. (Bridgewater, N.J.) partnered to form virtual company
Telsar Pharma Inc.
...
Read More
Items per page:
10
1 - 6 of 6
BioCentury
|
May 23, 2016
Finance
Venturing west
...spinouts include nocturia therapeutic developer Tacurion Pharma Inc. and gastrointestinal companies Seldar Pharma Inc. and
Telsar Pharma Inc.
...
Read More
BioCentury
|
May 13, 2013
Company News
Drais, Tacurion, Astellas deal
...In a pair of similar deals announced last year, Astellas and Drais formed virtual companies
Telsar Pharma Inc.
...
Read More
BioCentury
|
May 8, 2013
Company News
Astellas, Drais form newco to develop Astellas nocturia compound
...In a pair of similar deals announced last year, Astellas and Drais formed virtual companies
Telsar Pharma Inc.
...
Read More
BioCentury
|
Jun 5, 2012
Company News
Astellas, Drais form newco to develop Astellas' IBS product
...milestone payment and royalties. In a similar deal in April, the partners formed virtual company
Telsar Pharma Inc.
...
Read More
BioCentury
|
Apr 30, 2012
Financial News
Telsar Pharma completes venture financing
Telsar Pharma Inc.
, Bridgewater, N.J. Business: Gastrointestinal Date completed: 4/24/12 Type: Venture financing Raised: $14 million Investors: InterWest Partners; Sutter Hill Ventures; Astellas Venture Management WIR Staff...
Read More
BioCentury
|
Apr 26, 2012
Company News
Astellas, Drais form newco to develop Astellas' ASP3291
...Astellas Pharma Inc. (Tokyo:4503) and Drais Pharmaceuticals Inc. (Bridgewater, N.J.) partnered to form virtual company
Telsar Pharma Inc.
...
Read More
Items per page:
10
1 - 6 of 6
Previous page
Next page